Indications for transcatheter aortic valve replacement based on the PARTNER trial;Indicaciones de prótesis aórtica percutánea después del estudio PARTNER

Revista Espanola de Cardiologia

Volumn 65, Issue 3, 2012, Pages 208-214

  Rodés Cabau, Josep ^a   Urena, Marina ^a   Nombela Franco, Luis ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

REVIEW; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT INDICATION;

EID: 84857501415     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2011.10.017     Document Type: Article

References (20)

1. B. Lung, G. Baron, E.G. Butchart, F. Delahaye, C. Gohlke-Barwolf, and O.W. Levang A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease Eur Heart J 24 2003 1231 1243 (Pubitemid 36834640)
2. A. Cribier, H. Eltchaninoff, A. Bash, N. Borenstein, C. Tron, and F. Bauer Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description Circulation 106 2002 3006 3008 (Pubitemid 35440280)
3. N. Piazza, E. Grube, U. Gerckens, P. Den Heijer, A. Linke, and O. Luha Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval EuroIntervention 4 2008 242 249
4. J. Rodés-Cabau, J.G. Webb, A. Cheung, J. Ye, E. Dumont, and C.M. Feindel Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience J Am Coll Cardiol 55 2009 1080 1090
5. ® en pacientes con estenosis aórtica severa: experiencia inicial en España Rev Esp Cardiol 63 2010 141 148
6. M. Thomas, G. Schymik, T. Walther, D. Himbert, T. Lefevre, and H. Treede Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve Circulation 122 2010 62 69
7. M. Thomas, G. Schymik, T. Walther, D. Himbert, T. Lefevre, and H. Treede One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve Circulation 124 2011 425 433
8. R. Zahn, U. Gerckens, E. Grube, A. Linke, H. Sievert, and H. Eggebrecht Transcatheter aortic valve implantation: first results from a multi-centre real-world registry Eur Heart J 32 2010 198 204
9. C. Tamburino, D. Capodanno, A. Ramondo, A.S. Petronio, F. Ettori, and G. Santoro Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis Circulation 123 2011 299 308
10. J.M. Bosmans, J. Kefer, B. De Bruyne, P. Herijgers, C. Dubois, and V. Legrand Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry Interact Cardiovasc Thorac Surg 12 2011 762 767
11. H. Eltchaninoff, A. Prat, M. Gilard, A. Leguerrier, D. Blanchard, and G. Fournial Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry Eur Heart J 32 2010 191 197
12. N.E. Moat, P. Ludman, M.A. Belder, B. Bridgewater, A.D. Cunningham, and C.P. Young Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis. The U. K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry J Am Coll Cardiol 58 2011 2130 2138
13. C.R. Smith, M.B. Leon, M.J. Mack, D.C. Miller, J.W. Moses, and L.G. Svensson Transcatheter versus surgical aortic-valve replacement in high-risk patients N Engl J Med 364 2011 2187 2198
14. M.B. Leon, C.R. Smith, M. Mack, D.C. Miller, J.W. Moses, and L.G. Svensson Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
15. M.R. Reynolds, E.A. Magnuson, Y. Lei, M.B. Leon, C.R. Smith, and L.G. Svensson Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis Circulation 124 2011 1964 1972
16. J.G. Webb, D.A. Wood, J. Ye, R. Gurvitch, J.B. Masson, and J. Rodes-Cabau Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves Circulation 121 2010 1848 1857
17. P. Kahlert, P. Doettger, K. Mori, F. Al-Rashid, M. Thielmann, and D. Wendt Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study Circulation 122 2010 A A18122
18. Amat-Santos I, Rodés Cabau J, Urena M, Delarochellire R, Doyle D, Bagur R, et al. Incidence, predictive factors and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. J Am Coll Cardiol. 2012;59:178-88.
19. Miller C, Blackstone EH, Mack MJ, Svensson LG, Kodali SK, Kapadia S, et al. Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurological events in the PARTNER Trial. J Thorac Cardiovasc Surg. 2012 [en prensa].
20. R. Gurvitch, D.A. Wood, E.L. Tay, J. Leipsic, J. Ye, and S.V. Lichtenstein Transcatheter aortic valve implantation: durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort Circulation 122 2010 1319 1327